India
· Delayed Price · Currency is INR Gufic Biosciences Statistics
Total Valuation
BOM:509079 has a market cap or net worth of INR 36.20 billion. The enterprise value is 38.96 billion.
| Market Cap | 36.20B |
| Enterprise Value | 38.96B |
Important Dates
The next estimated earnings date is Thursday, May 29, 2025.
| Earnings Date | May 29, 2025 |
| Ex-Dividend Date | Sep 17, 2024 |
Share Statistics
BOM:509079 has 100.28 million shares outstanding. The number of shares has increased by 2.69% in one year.
| Current Share Class | n/a |
| Shares Outstanding | 100.28M |
| Shares Change (YoY) | +2.69% |
| Shares Change (QoQ) | -0.29% |
| Owned by Insiders (%) | 44.41% |
| Owned by Institutions (%) | 6.50% |
| Float | 24.74M |
Valuation Ratios
The trailing PE ratio is 44.15.
| PE Ratio | 44.15 |
| Forward PE | n/a |
| PS Ratio | 4.47 |
| PB Ratio | 6.30 |
| P/TBV Ratio | 6.37 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | 47.53 |
| EV / Sales | 4.81 |
| EV / EBITDA | 27.88 |
| EV / EBIT | 30.61 |
| EV / FCF | n/a |
Financial Position
| Current Ratio | n/a |
| Quick Ratio | n/a |
| Debt / Equity | 0.52 |
| Debt / EBITDA | 2.12 |
| Debt / FCF | n/a |
| Interest Coverage | 7.25 |
Financial Efficiency
| Return on Equity (ROE) | n/a |
| Return on Assets (ROA) | n/a |
| Return on Invested Capital (ROIC) | 9.82% |
| Return on Capital Employed (ROCE) | n/a |
| Revenue Per Employee | 5.43M |
| Profits Per Employee | 549,805 |
| Employee Count | 1,491 |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +12.48% in the last 52 weeks. The beta is 0.72, so BOM:509079's price volatility has been lower than the market average.
| Beta (5Y) | 0.72 |
| 52-Week Price Change | +12.48% |
| 50-Day Moving Average | 356.05 |
| 200-Day Moving Average | 397.21 |
| Relative Strength Index (RSI) | 65.71 |
| Average Volume (20 Days) | 6,580 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, BOM:509079 had revenue of INR 8.10 billion and earned 819.76 million in profits. Earnings per share was 8.17.
| Revenue | 8.10B |
| Gross Profit | 4.27B |
| Operating Income | 1.27B |
| Pretax Income | 1.11B |
| Net Income | 819.76M |
| EBITDA | 1.33B |
| EBIT | 1.27B |
| Earnings Per Share (EPS) | 8.17 |
Balance Sheet
The company has 193.96 million in cash and 2.96 billion in debt, giving a net cash position of -2.77 billion or -27.58 per share.
| Cash & Cash Equivalents | 193.96M |
| Total Debt | 2.96B |
| Net Cash | -2.77B |
| Net Cash Per Share | -27.58 |
| Equity (Book Value) | 5.74B |
| Book Value Per Share | 57.24 |
| Working Capital | n/a |
Cash Flow
| Operating Cash Flow | n/a |
| Capital Expenditures | n/a |
| Free Cash Flow | n/a |
| FCF Per Share | n/a |
Margins
Gross margin is 52.78%, with operating and profit margins of 15.72% and 10.12%.
| Gross Margin | 52.78% |
| Operating Margin | 15.72% |
| Pretax Margin | 13.68% |
| Profit Margin | 10.12% |
| EBITDA Margin | 16.38% |
| EBIT Margin | 15.72% |
| FCF Margin | n/a |
Dividends & Yields
This stock pays an annual dividend of 0.10, which amounts to a dividend yield of 0.03%.
| Dividend Per Share | 0.10 |
| Dividend Yield | 0.03% |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -2.69% |
| Shareholder Yield | -2.66% |
| Earnings Yield | 2.26% |
| FCF Yield | n/a |
Stock Splits
The last stock split was on October 29, 2002. It was a forward split with a ratio of 10.
| Last Split Date | Oct 29, 2002 |
| Split Type | Forward |
| Split Ratio | 10 |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | n/a |